Catalyst Pharmaceutical CPRX Increase (Decrease) in Deferred Income Taxes
Increase (Decrease) in Deferred Income Taxes at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredIncomeTaxes.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's increase (decrease) in deferred income taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's increase (decrease) in deferred income taxes?
- Catalyst Pharmaceutical (CPRX) reported increase (decrease) in deferred income taxes of $2.34M in Q1 2026.
- How has Catalyst Pharmaceutical's increase (decrease) in deferred income taxes changed year-over-year?
- Catalyst Pharmaceutical's increase (decrease) in deferred income taxes increased by 0.6% year-over-year, from $2.32M to $2.34M.
- What is the long-term trend for Catalyst Pharmaceutical's increase (decrease) in deferred income taxes?
- Over 2 years (2021 to 2023), Catalyst Pharmaceutical's increase (decrease) in deferred income taxes has grown at a 41.7% compound annual growth rate (CAGR), from -$9.32M to $18.7M.